Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Physiomics Share News (PYC)
PYC Share
Price
PYC Share
News
PYC Share
Chat3
PYC Share
Trades9
PYC
Live RNS
PYC Share
Charts
PYC Level 2
Console
PYC Live
Share Price
PYC Broker
Ratings
PYC Directors
Deals
PYC Financial
Diary
PYC
Fundamentals
PYC Short
Positions
PYC
Media
PYC Company
Research
PYC Company
Timeline
Share Price Information for Physiomics (PYC)
Last checked at -
Last checked at 
Intraday Physiomics Share Chart
LONDON (Alliance News) - Physiomics PLC Monday said it has signed a contract with a new speciality pharmaceuticals customer to investigate how one of the client's new candidate drugs shrinks tumours.
Physiomics scientists will use systems biology approaches to map the possible pathways by which the drug could act, it said in a statement without giving any financial details. The analysis will be used to narrow down possible mechanisms and suggest new experiments that the client can perform to home in on one mechanism.
"If successful, the directors hope that Physiomics will be able to offer its other modelling services to this new client as the project progresses," the company said in a statement.
Physiomics shares were up 31.6% at 0.25 pence early Monday, the biggest gainer on AIM.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.
Latest PYC News
- EARNINGS UPDATES: Crestchic raises outlook on record year-to-date
29 Sep 2022 - UK earnings, trading statements calendar - next 7 days
22 Sep 2022 - TRADING UPDATES: Michelmersh Brick, Mattioli Woods on-track for growth
7 Jul 2022 - IN BRIEF: Physiomics wins new contract for Virtual Tumour platform
8 Apr 2022 - Physiomics wins new contract with French pharma company
8 Apr 2022 - IN BRIEF: Physiomics confident for full-year, in talks for new client
7 Mar 2022 - TRADING UPDATES: MediaZest virus hit; SpaceandPeople Network Rail deal
2 Mar 2022 - IN BRIEF: Physiomics chair steps down after 15 years; CEO adds role
23 Feb 2022
Related News
Physiomics reports strong operational progress
(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...
Physiomics reports strong operational progress
(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...
Physiomics hails progress despite one-off costs to replace board
(Alliance News) - Physiomics PLC on Friday said it "continues to make strong operational progress" but noted one-off costs from the dismissal of its p...
Physiomics News
EARNINGS UPDATES: Crestchic raises outlook on record year-to-date
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
TRADING UPDATES: Michelmersh Brick, Mattioli Woods on-track for growth
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
IN BRIEF: Physiomics wins new contract for Virtual Tumour platform
Physiomics PLC - oncology consultancy based in Oxford, England - Wins new contract with Servier Group, an international pharmaceutical company with he...
Physiomics wins new contract with French pharma company
(Sharecast News) - Oncology drug developer Physiomics has been awarded a contract by new client, the Servier Group, an international pharmaceutical co...
IN BRIEF: Physiomics confident for full-year, in talks for new client
Physiomics PLC - oncology consultancy based in Oxford, England - Pretax loss widens to GBP170,000 in six months that ended December 31 from GBP132,000...
TRADING UPDATES: MediaZest virus hit; SpaceandPeople Network Rail deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
IN BRIEF: Physiomics chair steps down after 15 years; CEO adds role
Physiomics PLC - oncology consultancy based in Oxford, England - Non-Executive Chair Paul Harper steps down from board immediately, having served on t...
Follow the stocks
